Opendata, web and dolomites

LiveRest SIGNED

Intelligent control system based on smart textiles to reduce pressure injury risk by real time measure of tissue viability, and intelligent trigger of prevention strategies adapted to user and context

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LiveRest project word cloud

Explore the words cloud of the LiveRest project. It provides you a very rough idea of what is the project "LiveRest" about.

treatment    commercialise    extra    aligned    living    care    independent    plan    commercial    sci    temperature    status    customers    environment    strategies    novelties       viability    solution    combination    device    risk    patients    million    labour    health    ict    public    liverest    strategy    uses    ready    social    lot    pressure    cord    business    injuries    complications    decide    disruptive    mass    prevention    humidity    clinically    human    combined    personalised    billion    repositioning    injury    savings    enhanced    context    assistive    ing    resource    impedance    tv    investor    appear    pi    caregivers    time    demonstrates    compensation    perform    medical    textile    plus    disability    spinal    38    preventable    global    hospital    takes    inclusion    market    marketability    hospitals    ageing    ephs    die    elaborate    commercialisation    causes    sensors    job    wheelchair    free    actuation    tissue    beds    sitting    instead    85    benefits   

Project "LiveRest" data sheet

The following table provides information about the project.

Coordinator
QIMOVA AS 

Organization address
address: LILLE HAVDRUPVEJ 5 GI HAVDRUP
city: HAVDRUP
postcode: 4622
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 2˙016˙546 €
 EC max contribution 1˙411˙582 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2020-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    QIMOVA AS DK (HAVDRUP) coordinator 1˙411˙582.00

Map

 Project objective

85% of Spinal Cord Injury (SCI) patients will develop a Pressure Injury (PI), and 8% of them will die due to associated complications. PI treatment costs €20 billion per year to the European Public Health System (EPHS), uses a lot of resources (e.g. caregivers and hospital beds) and causes injuries to the caregivers that perform repositioning of the patients, resulting in compensation costs and extra human resource reduction. PI are preventable, however 38% of PI appear using current commercial prevention devices because PI risk assessment is only based on pressure instead of Tissue Viability (TV) which also takes into account user status and context. The aim of this project is to demonstrate in operational environment, produce and commercialise in the Assistive Technology market LiveRest system, a disruptive ICT solution that is able to avoid the development of PI, being the only device on the market that clinically demonstrates PI prevention. LiveRest will be embedded on a personalised wheelchair, and its novelties are: a) to measure PI risk in real time based on TV with impedance, pressure, temperature and humidity textile sensors; b) to decide the best combination of PI prevention strategies based on risk, user and context; and c) to perform the selected strategy based on combined actuation systems. LiveRest is aligned with key EU global challenges: disability, independent living, job inclusion, reduction of social and health care costs, and increase of labour. Target customers are SCI patients and hospitals. Benefits for the patients are increased sitting time and enhanced health, social inclusion, independent living and ageing well. EPHS savings will result in more than €40 million per year, plus avoid loss of medical resources. During Phase 2, we will achieve the free marketability of LiveRest, demonstrate the system in operational environment and elaborate an investor-ready business plan, including commercialisation and mass-production strategies.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIVEREST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIVEREST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

Genetta (2019)

Pole climbing solution to improve safety at work and to prevent fatal accidents in industrial climbing

Read More  

SQP (2019)

Opening new markets for Single Quantum Photodetectors

Read More